The Patent Finder

Integrated Continuous Manufacturing of Therapeutic Protein Drug Substances

Genzyme Corporation

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application 61/775,060, filed Mar 8, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,650,412Integrated Continuous Manufacturing of Therapeutic Protein Drug Substances
In force
 · High confidence
UsedRemaining
Genzyme CorporationIn forceHigh confidence
US 9,650,413Integrated Continuous Manufacturing of Therapeutic Protein Drug Substances
In force
 · Medium confidence
Genzyme CorporationIn forceMedium confidence
US 9,657,056Integrated Continuous Manufacturing of Therapeutic Protein Drug Substances
In force
 · High confidence
Genzyme CorporationIn forceHigh confidence
US 10,711,034Integrated Continuous Manufacturing of Therapeutic Protein Drug Substances
In force
 · Low confidence
Genzyme CorporationIn forceLow confidence
US 12,110,312Integrated Continuous Manufacturing of Therapeutic Protein Drug Substances
In force
 · Low confidence
Genzyme CorporationIn forceLow confidence
Application 18/817,164Integrated Continuous Manufacturing of Therapeutic Protein Drug Substances
Pending
Not granted
Genzyme CorporationPendingNot granted
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Genzyme Corporation.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited